期刊文献+

孟鲁司特治疗毛细支气管炎的疗效及预防喘息反复发作的作用 被引量:12

Curative effect and decreasing the incidence of asthma following bronchiolitis of Montelukast
下载PDF
导出
摘要 目的探讨孟鲁司特治疗毛细支气管炎的疗效和预防喘息反复发作的作用。方法将确诊为毛细支气管炎的90例患者随机分为两组,治疗组45例,对照组45例。两组均给予常规治疗,治疗组加用孟鲁司特口服每晚4 mg,共4周,进行为期1年的跟踪随访。结果咳嗽、喘憋消失时间和肺部体征消失时间均短于对照组(P<0.01),且喘息反复发作次数低于对照组(P<0.01)。结论孟鲁司特治疗毛细支气管炎疗效显著,无不良反应,且能预防喘息的发生和反复发作。 Objective To study the curative effect of Montelukast in bronchiolitis and to evaluate the efficiency of montelukast in decreasing the incidence of asthma following brochiolitis.Methods 90 cases bronchiolitis were categorized in two groups,therapy group 45 cases and control group 45 cases,conventional Medical treatment were given in two groups,Montelukast was appendant in therapy group,4mg,qn,4 weeks.The time of follow up was over 1 year.Results The cure rate of therapy group was significant higher than control group(P〈0.01),the difference had statistical value.Incidence of asthma following brochiolitis with montelukast was less than without montelukast.Conclusion Montelukast can conspicuous increase the therapy effects of bronchiolitis,Montelukast is an effective way to decrease the incidence of asthma following brochiolitis.Using Montelukast is a good way to precaut the asthma following brochiolitis,and it is not adverse reactions.
作者 吕瑗玲
出处 《重庆医学》 CAS CSCD 北大核心 2010年第20期2753-2754,共2页 Chongqing medicine
关键词 孟鲁司特 毛细支气管炎 治疗 预防 montelukast bronchiolitis treatment precaution
  • 相关文献

参考文献6

二级参考文献32

  • 1王献忠,庞维胜,申长清.婴儿毛细支气管炎治疗进展[J].中原医刊,2004,31(15):40-41. 被引量:7
  • 2李兰,王智斌,李敏,陈昌辉,李波,吉德平,王运芳.毛细支气管炎血中半胱氨酰白三烯的测定及意义[J].四川大学学报(医学版),2005,36(2):297-297. 被引量:27
  • 3金小红,王昕昕,李绍波,干灵红.支气管哮喘儿童尿白三烯E4的变化[J].基础医学与临床,2005,25(12):1175-1176. 被引量:7
  • 4美国儿科学会.毛细支气管炎诊治指南.Pediatrics,2006,118(4):1774-1774.
  • 5Allander T, Emerson S, Engle RE, et al. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species [J]. PNAS, 2001, 98 (20) : 11609-11614.
  • 6Law B J, Carbonell-Estrany X, Simors EA. An update on respiratory. syncytial virus epidemiology: a developed country perspective[J].Respir Med,2002, 96(Suppl B) : 1-7.
  • 7Sigurs N, Bjamason R, Sigurbergason F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7 [J]. Am J Respir Crit Care Med , 2000,161 : 1501-1507.
  • 8Pala P, Bjarnason R, Sigurbergasson f, et al , Enhanced IL-4 responses in children with a history of resoiratory syncylial virus bronchiolitis in infancy [J ]. Eur Respir J, 2002, 20:376-382.
  • 9Wang SZ, BaoYZ, Rosenberger CL. IL- 12 p40 and IL- 18 modulale inflammalory and immune responses to respiratory syncytial virus infection [J]. J Immunol, 2004, 173(6) :4040-4049.
  • 10Hendeison WR, Jr, TangLo, ChuST, et al. A role for cystinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med , 2002,165 : 108-116.

共引文献179

同被引文献93

引证文献12

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部